Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.48 |
| ▸ | CYP19A1 | P11511 | 4/20 | 0.48 |
| ▸ | PPARG | P37231 | 3/20 | 0.48 |
| ▸ | OXER1 | Q8TDS5 | 3/20 | 0.48 |
| ▸ | MAPT | P10636 | 3/20 | 0.48 |
| ▸ | RXRA | P19793 | 2/20 | 0.48 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.48 |
| ▸ | PTGS1 | P23219 | 4/20 | 0.45 |
| ▸ | F7 | P08709 | 3/20 | 0.45 |
| ▸ | F3 | P13726 | 3/20 | 0.45 |
| ▸ | PPARA | Q07869 | 3/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | PPARD | Q03181 | 2/20 | 0.45 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.45 |
| ▸ | NR1I2 | O75469 | 2/20 | 0.42 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1476325 | 1.00 | ALDH1A1 (0.48) | ALDH1A1CYP19A1PPARGOXER1MAPT | |
| SCHEMBL9766332 | 1.00 | ALDH1A1 (0.48) | ALDH1A1CYP19A1PPARGOXER1MAPT | |
| SCHEMBL606594 | 1.00 | ALDH1A1 (0.48) | ALDH1A1CYP19A1PPARGOXER1MAPT | |
| SCHEMBL18837286 | 1.00 | ALDH1A1 (0.48) | ALDH1A1CYP19A1PPARGOXER1MAPT | |
| SCHEMBL9766336 | 1.00 | ALDH1A1 (0.48) | ALDH1A1CYP19A1PPARGOXER1MAPT | |
| SCHEMBL606595 | 1.00 | ALDH1A1 (0.48) | ALDH1A1CYP19A1PPARGOXER1MAPT | |
| SCHEMBL5457684 | 1.00 | ALDH1A1 (0.48) | ALDH1A1CYP19A1PPARGOXER1MAPT | |
| SCHEMBL1611597 | 1.00 | ALDH1A1 (0.48) | ALDH1A1CYP19A1PPARGOXER1MAPT | |
| SCHEMBL3685895 | 1.00 | ALDH1A1 (0.48) | ALDH1A1CYP19A1PPARGOXER1MAPT | |
| SCHEMBL5457682 | 1.00 | ALDH1A1 (0.48) | ALDH1A1CYP19A1PPARGOXER1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024117128-A1 | INTRAOCULAR PRESSURE LOWERING AGENT, AND AGENT FOR TREATING OR PREVENTING GLAUCOMA OR OCULAR HYPERTENSION | ＳＡＮＳＨＯ株式会社 | 2024-06-06 | — | — | WO | disclosed |
| US-20240115586-A1 | THERAPEUTIC AGENT FOR PULMONARY FIBROSIS | SANSHO CO. LTD. (JP) | 2024-04-11 | — | — | US | disclosed |
| EP-4252756-A1 | THERAPEUTIC AGENT FOR PULMONARY FIBROSIS | Sansho Co., Ltd. (JP) | 2023-10-04 | — | — | EP | disclosed |
| US-20230108750-A1 | CARBALYSOPHOSPHATIDIC ACID | OCHANOMIZU UNIVERSITY (JP) | 2023-04-06 | — | — | US | disclosed |
| US-10413559-B2 | Method for treating demyelinating disease | OCHANOMIZU UNIVERSITY (JP) | 2019-09-17 | — | — | US | disclosed |
| EP-2949329-B1 | THERAPEUTIC AGENT FOR DEMYELINATING DISEASE | UNIV OCHANOMIZU (JP) | 2019-05-01 | — | — | EP | disclosed |
| EP-2803359-B1 | THERAPEUTIC AGENT FOR JOINT DISEASES | SANSHO CO (JP) | 2017-04-19 | — | — | EP | disclosed |
| US-20150352132-A1 | THERAPEUTIC AGENT FOR DEMYELINATING DISEASE | OCHANOMIZU UNIVERSITY (JP) | 2015-12-10 | — | — | US | disclosed |
| EP-2949329-A1 | THERAPEUTIC AGENT FOR DEMYELINATING DISEASE | Ochanomizu University (JP) | 2015-12-02 | — | — | EP | disclosed |
| US-9085593-B2 | Therapeutic agent for arthrosis | SANSHO CO., LTD. (JP) | 2015-07-21 | — | — | US | disclosed |
| US-6750332-B1 | HAVE VALUABLE COSMETICALLY AND PHARMACEUTICALLY USEFUL PROPERTIES, SUCH AS PROSTAGLANDIN SYNTHESIS INHIBITION; SALICIN ESTERS | COGNIS DEUTSCHLAND GMBH & CO. KG (DE) | 2004-06-15 | — | — | US | disclosed |
| EP-1402894-A1 | CANCEROUS METASTASIS INHIBITORS CONTAINING CARBACYCLIC PHOSPHATIDIC ACID DERIVATIVES | Gencom Corporation (JP) | 2004-03-31 | — | — | EP | disclosed |
| EP-1391204-A1 | NERVE CELL SURVIVAL PROMOTERS CONTAINING CYCLIC PHOSPHATIDIC ACID DERIVATIVE | Gencom Corporation (JP) | 2004-02-25 | — | — | EP | disclosed |
| EP-1386612-A1 | DRUGS FO RPROMOTING THE PROLIFERATION, DIFFERENTIATION AND/OR SURVIVAL OF GLIAL CELLS CONTAINING CYCLIC PHOSPHATIDIC ACID | Gencom Corporation (JP) | 2004-02-04 | — | — | EP | disclosed |
| US-20030166707-A1 | Microsphaeropsin B as novel antibacterial agent, process for producing the same and pharmaceutical composition containing thereof | NAEJA PHARMACEUTICAL INC. (CA) | 2003-09-04 | — | — | US | disclosed |
| US-5962438-A | OSTEOPOROSIS | SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) | 1999-10-05 | — | — | US | disclosed |
| EP-0827951-A1 | NOVEL BONE-SEEKING ESTROGEN DERIVATIVE | SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) | 1998-03-11 | — | — | EP | disclosed |
| EP-0625507-B1 | Urea derivatives and their use as acat inhibitors | NISSHIN FLOUR MILLING CO (JP) | 1997-07-23 | — | — | EP | disclosed |
| US-5621010-A | ANTIHYPERCHOLESTEROLEMIA AND ANTIATHEROSCLEROSIS | NISSHIN FLOUR MILLING CO., LTD. (JP) | 1997-04-15 | — | — | US | disclosed |
| EP-0625507-A2 | Urea derivatives and their use as acat inhibitors | NISSHIN FLOUR MILLING CO., LTD. (JP) | 1994-11-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230108750-A1 | CARBALYSOPHOSPHATIDIC ACID | PHOSPHO1, SGMS1, PLD1 | ALDH1A1 3690/4885CYP19A1 2535/4885PPARG 1990/4885 |
| US-20150352132-A1 | THERAPEUTIC AGENT FOR DEMYELINATING DISEASE | PMP22, MAG, SGMS1 | ALDH1A1 3983/4885CYP19A1 4850/4885PPARG 1821/4885 |
| US-20030166707-A1 | Microsphaeropsin B as novel antibacterial agent, process for producing the same and pharmaceutical composition containing thereof | VIP, CETP, MTMR1 | ALDH1A1 4522/4885CYP19A1 2138/4885PPARG 2755/4885 |
| US-10413559-B2 | Method for treating demyelinating disease | PMP22, MAG, SGMS1 | ALDH1A1 3689/4885CYP19A1 4694/4885PPARG 1408/4885 |
| US-20240115586-A1 | THERAPEUTIC AGENT FOR PULMONARY FIBROSIS | CCL11, ELANE, MMP1 | ALDH1A1 626/4885CYP19A1 4730/4885PPARG 403/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.